Dr Joy Wolfram from the Mayo Clinic explains how nanomedicine has the potential to change the way we treat disease.

Filmed at the 2017 Hello Tomorrow Global Summit.

Joy Wolfram, Ph.D., focuses her research in nanomedicine on the development of new strategies for the treatment of disease. In particular, her team is developing extracellular vesicle therapeutics and methods for organotropic drug delivery. Dr. Wolfram aspires to generate fruitful interinstitutional research collaborations around the world.

The Nanomedicine and Extracellular Vesicles Laboratory of Joy Wolfram, Ph.D., at Mayo Clinic

www.hello-tomorrow.org

 

Recent News

GHCE Concept

From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first [...]